CR Rate, DFS, and Survival Versus Number of T-Cell Markers Expressed
| Group (no. of markers) . | No. of Patients . | CR (%) . | Probability of DFS at 3 yr (95% CI) . | P5-150 . | Probability of Survival at 3 yr (95% CI) . | P5-150 . |
|---|---|---|---|---|---|---|
| 1-3 | 10 | 6 (60%) | 0.17 (0.05-0.45) | — | 0.30 (0.12-0.57) | — |
| 4-5 | 20 | 18 (90%) | 0.58 (0.29-0.81) | .13 | 0.62 (0.36-0.82) | .13 |
| 6-7 | 14 | 14 (100%) | 0.86 (0.59-0.96) | .003 | 0.86 (0.60-0.96) | .004 |
| Group (no. of markers) . | No. of Patients . | CR (%) . | Probability of DFS at 3 yr (95% CI) . | P5-150 . | Probability of Survival at 3 yr (95% CI) . | P5-150 . |
|---|---|---|---|---|---|---|
| 1-3 | 10 | 6 (60%) | 0.17 (0.05-0.45) | — | 0.30 (0.12-0.57) | — |
| 4-5 | 20 | 18 (90%) | 0.58 (0.29-0.81) | .13 | 0.62 (0.36-0.82) | .13 |
| 6-7 | 14 | 14 (100%) | 0.86 (0.59-0.96) | .003 | 0.86 (0.60-0.96) | .004 |
Adjusted P value by logrank comparing 1-3 marker group with 4-5 or 6-7 marker group.